drugset / Trial / NCT05448456

Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail

NCT05448456

Phase 4 Completed 150 enrolled Assuta Ashdod Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The objective of this study is to assess the effect of TA treatment on decline in Hb levels following vaginal delivery with an episiotomy, compared to a control group not receiving TA.

Timeline

Start
2022-07-25
Primary completion
2023-08-22
Completion
2024-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications